Transgenic animals having a modified glycoprotein V gene

Details Transgenic animals having a modified glycoprotein V gene Transgenic animals having a modified glycoprotein V gene

2005-10-11

2005-10-11

Priebe, Scott D. (Department: 1635)

Multicellular living organisms and unmodified parts thereof and

Method of using a transgenic nonhuman animal in an in vivo...

C800S009000, C800S018000, C800S021000, C800S025000, C435S325000, C435S354000, C435S355000

Reexamination Certificate

active

06953874

ABSTRACT:
The present invention relates to nonhuman transgenic animals in which the GP V gene has been modified. The invention is also useful for identifying agents that modulate the biological functions of GP V, including the screening and identification of potential therapeutic agents.

REFERENCES:
patent: 5413923 (1995-05-01), Kucherlapati et al.
patent: WO 99/53032 (1999-10-01), None
Moreadith et al., J. Mol. Med. 75:208-216, 1997.
Ravanat et al., Blood. ;89:3253-62, 1997.
Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, Birkhauser Boston, 1994, pp. 491-494.
Chiu et al., Folding and Design, 1998, pp. 223-228.
L-M Houdebine, Journal of Biotechnology, “Production of pharmaceutical proteins from transgenic animals,” 1994, 34,pp. 269-287.
RM Strojek et al., Genetic Engineering:Principles and methods, “ The use of transgenic animal techniques for livestock improvement,” 1988, vol. 10, pp. 221-246.
LJ Mullins et al., Perspectives Series: Molecular Medicine in Genetically Engineered Animals,“Transgenesis in the Rat and Larger Mammals,” Apr. 1996, vol. 97, No. 7, pp. 1557-1560.
RJ Wall, Theriogenology, “Transgenic Livestock: Progress and Prospects for the Future,” 1996, 45:57-68.
T Rulicke et al.,Experimental Physiology, “Special Review Series-Gene Manipulation and Integrative Physiology,”2000,85.6,pp. 589-601.
JO Bishop, Reprod Nutr Dev., “Chromosomal insertion of foreign DNA,” 1996,36,pp. 607-618.
IA Polejaeva et al., Theriogenology, “New Advances in Somatic Cell Nuclear Transfer: Application in Transgenesis,” 2000, 53: pp. 117-126.
CD Sigmund, Arterioscler Thromb Vasc Biol., “Viewpoint: Are Studies in Genetically Altered Mice Out of Control?,”2000;20:1425-1429.
D Humpherys et al., Science, “Epigenetic Instability in ES Cells and Cloned Mice,” Jul.2001, vol. 293, pp. 95-97.
S Moog et al., Hemostasis, Thrombosis and Vascular Biology,“Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation,” Aug. 2001, vol. 98, No. 4, pp. 1038-1046.
ML Kahn et al., Hemostasis, Thrombosis, and Vascular Biology, “Glycoprotein V-Deficient Platelets have undiminished Thrombin Responsiveness and Do not Exhibit a Bernard-Soulier Phenotype,” Dec. 1999, vol. 94, No. 12, pp. 4112-4121.
Dong et al., (1997) Role of Glycoprotein V in the Formation of the Platelet High-Affinity Thrombin- Binding Site, Blood 89, 4355-4363.
Law et al., (1999) Signal Transduction Pathways for Mouse Platelet Membrane Adhesion Receptors, Thrombosis & Haemostasis 82, 345-352.
Ramakrishnan et al., (1999) Increased Thrombin Responsiveness in Platelets From Mice Lacking Glycoprotein V, Proceedings of the National Academy of Sciences of USA 96, 13336-13341.
Ramakrishnan et al., (1998) Targeted Deletion of the GPV Gene in Mice: A Model For Studying the Functional Role of GPV in Mouse Platelets, Blood 92, suppl. 1, abstract #1434.

Affiliated with

Also associated with

Rating

Transgenic animals having a modified glycoprotein V gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic animals having a modified glycoprotein V gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic animals having a modified glycoprotein V gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3439384